ISPOR ANNOUNCES CALL FOR NOMINATIONS

Published Oct 19, 2015
SUBMISSIONS BEING ACCEPTED FOR 2016-2017 BOARD OF DIRECTORS Princeton, NJ—October 19, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today that it is accepting nominations for the 2016-2017 Board of Directors. Board openings include President-Elect and four Director positions. As a member-driven organization, ISPOR relies on the participation of its members to fulfill the organization’s mission. Participating on the Board enables ISPOR members to lend their leadership, expertise, and vision to the discipline of health economics and outcomes research. The Board of Directors drives ISPOR’s strategic direction and is responsible for the management of the Society, including its committees, publications, budget and governance. The Board is the policy making body of the Society. Members may submit nominations on behalf of other ISPOR members or may self-nominate. Additional details on the nomination process may be found at http://www.ispor.org/board/CallForNominations-BOD2016.asp. Information on the 2015-2016 Board of Directors members (including terms of office) can be found at http://www.ispor.org/board/index.asp. The deadline for submitting nominations is January 1, 2016.

###

Related Stories

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.

How Is Health Valued in the United Kingdom? We Finally Have a Better Answer

May 27, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a pair of companion articles that together establish both the methodological foundation of the first definitive UK value set for the EQ-5D-5L and the practical implications of adopting it—thus equipping health technology assessment decision makers with a UK value set suitable for informing policy. The articles were featured in the May 2026 issue of Value in Health.

ISPOR Announces 2026-2027 Board of Directors

May 26, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research announced its 2026-2027 board of directors who will assume office on July 1, 2026.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×